在癌症治疗中使用抗体-药物结合剂:当前的进展和突破的前景
Dan Wu1,2,3, Kaixuan Yang1,2, Runjia He4
1Cancer Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in cell and developmental biology
|October 24, 2025
概括
抗体-药物合物 (ADC) 是一种先进的癌症疗法,针对具有细胞毒性有效载荷的瘤. 虽然有效,但需要进一步的研究来优化ADC和克服耐药性,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
- 生物技术是生物技术.
背景情况:
- 抗体-药物合物 (ADC) 是一种向癌症治疗方法.
- ADCs将单克隆抗体 (mAbs) 与细胞毒性有效载荷相结合,用于精确的瘤细胞输送.
- 与传统化疗相比,它们通过将健康组织的损伤降至最低来提供优势.
研究的目的:
- 为癌症治疗的ADC提供了近期进展的全面概述.
- 讨论已批准的ADCs的历史演变,结构设计,临床进展和作用机制.
- 突出未来发展的领域,包括下一代ADC.
主要方法:
- 审查瘤治疗的最新发展.
- 分析ADC的结构成分:抗原,mAb,链接系统和细胞毒性有效载荷.
- 检查有效载荷结合技术的进步.
主要成果:
- 经过批准的ADC证明了对瘤细胞的强效细胞毒素的精确传递.
- 关键的结构元素和结合技术对于ADC的开发至关重要.
- 限制包括不良影响,低于最佳的疗效和耐药性,需要进一步优化.
结论:
- 在ADC技术中,持续的改进和创新至关重要.
- 下一代ADC有望在癌症患者中提高治疗效益.
- 未来的方向包括探索与其他抗瘤策略的组合,以及新的ADC设计,如双特异性和双有效载荷ADC.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
952
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


